This symposium will address the various single-cell sequencing aspects by genomic tools. Attendees will also explore the potential clinical research in this field and anticipate the clinical application of single-cell sequencing technologies in neurological and inflammatory diseases.

The CPD-accredited symposium is an excellent opportunity for healthcare professionals to gain insights into the emerging field of single-cell genomics and engage with prominent international experts in this field from France (Imagine Institute) and Germany (Helmholtz Institute). 

Overall Learning Objectives

• Describe the basis of the latest advances in single-cell genomic technologies. 
• Illustrate how single-cell research improves our understanding of disease pathogenesis. 
• Define the potential clinical research areas in the field. 
• Discuss the future of single-cell sequencing applications in clinical practice, including diagnostics, prognostics, targeted therapy, and early detection.

This activity is a Category 1 - Accredited Group Learning Activity as defined by the Qatar Council for Healthcare Practitioners - Accreditation Department and is approved for 4.50 hours

Speakers

Dr. Nady El Hajj
Assistant Professor of Genomics and Precision Medicine, College of Health and Life Sciences, Hamad Bin Khalifa University
Dr. Antonio Rausell
Group leader, Clinical Bioinformatics, Imagine Institute, Paris (France) 
Dr. Lawrence Walter Stanton
Principal Investigator, Director, Neurological Disorders Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University
Dr. Mickaël Ménager 
Team Atip-Avenir, Inserm, Inflammatory Responses and Transcriptomic Networks in Diseases, Imagine Institute, Paris (France)
Dr. Antoine-Emmanuel Saliba 
Group leader, Helmholtz Institute for RNA-based infection research, University of Würzburg (Germany)

 

Register now